涉嫌事實
WANG MINGLIANG與英屬開曼群島康友製藥控股有限公司董事長黃文烈，於108年9月間，未經康友公司董事會決議通過，擅自將六華安源公司設備向大陸地區贛州銀行辦理動產抵押，用以擔保廈門奔馬實業有限公司之借款債務 Established by Huang Wen-Lai in November 2013, Pharmally International Holding Company Ltd. (Cayman) obtained 100% shares of Longterm Lista Limited around December 2013 and further acquired and controlled Luan Worldbest Pharmaceutical Company. Pharmally completed the registration of foreign company in Taiwan on January 6, 2015, and was listed on Taiwan Stock Exchange in March 2015. Pharmally set up PT. Biotis Prima Agrisindo in Indonesia in July 2016 and Pharmally Biological Company (PH), Inc. in the Philippines in November 2017. Defendant WANG MINGLIANG served as chairman of PT. Biotis Prima Agrisindo. The Defendant was fully aware that Huang Wen-Lai and WANG MINGLIANG were financing for working capital at the latest around August and September of 2019 owing to Xiamen Benma Industrial Co., Ltd., its subsidiary, Xiamen Sharing Group Co., Ltd., and its other subsidiaries being involved in a financial crisis. The Defendant, along with Huang and Wang, jointly used all of Luan Worldbest Pharmaceutical Company's 504 pieces of machinery and equipment as collateral for a chattel mortgage at the Xiamen branch of the Bank of Ganzhou in Mainland China on September 12, 2019 without a resolution approved by Pharmally's Board and then completed the registration on October 8, 2019. Consequently, as the guarantor of Xiamen Benma Industrial Co., Ltd. and its subsidiaries, Pharmally owed the bank RMB$237,220,000.
